Pure Global

Neuromuscular Electrical Stimulation in ICU Patients - Trial NCT04332263

Access comprehensive clinical trial information for NCT04332263 through Pure Global AI's free database. This phase not specified trial is sponsored by Federal University of Rio Grande do Sul and is currently Enrolling by invitation. The study focuses on Intensive Care Unit Acquired Weakness. Target enrollment is 56 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04332263
Enrolling by invitation
other
Trial Details
ClinicalTrials.gov โ€ข NCT04332263
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Neuromuscular Electrical Stimulation in ICU Patients
Development and Application of a Portable Electrical Stimulator With Biofeedback to Increase Mobility and Improve the Neuromuscular Function of Critical Adult Patients in Intensive Care Units

Study Focus

Neuromuscular Electrical Stimulation - NMES

Interventional

other

Sponsor & Location

Federal University of Rio Grande do Sul

Porto Alegre, Brazil

Timeline & Enrollment

N/A

Mar 01, 2022

Dec 20, 2024

56 participants

Primary Outcome

Total ICU time,Mechanical ventilation time,Weaning time,Change in knee extensor evoked force,Knee extensor maximal voluntary isometric contraction,Knee extensor muscle quality: Real-time ultrasound 9 MHz frequency,Rectus femoris cross-sectional area,Knee extensors muscle thickness

Summary

The aim of the present study is to evaluate the effects of neuromuscular electrical
 stimulation (NMES) combined with conventional physiotherapy (Experimental Group), compared to
 conventional physiotherapy only (Control Group) in critically ill Intensive Care Unit (ICU)
 patients, by means of a randomized controlled clinical trial. The investigators expect that
 the NMES program will be able to reduce muscle structure and function losses compared to
 control group, and will improve muscle quality faster, will reduce the ventilation time and
 the total time spent at the ICU, as well as improve functionality of these patients. In
 addition, the researchers expect to understand which mechanisms determine such adaptations in
 the musculoskeletal system of these patients.

ICD-10 Classifications

Acute respiratory failure
Acute renal failure with medullary necrosis
Acute renal failure
Acute renal failure, unspecified
Other acute renal failure

Data Source

ClinicalTrials.gov

NCT04332263

Non-Device Trial